Company intelligence / Profile preview

Babel Ventures

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Babel Ventures is a venture capital firm based in San Francisco that specializes in early-stage investments within the biotechnology and life sciences sectors. The firm focuses on disruptive technologies in areas such as longevity, synthetic biology, and health-tech. By providing capital and strategic support, Babel Ventures aims to accelerate the growth of companies developing innovative solutions for human health and sustainability. Their portfolio includes notable startups in the synthetic biology and deep-tech spaces. The firm typically engages at the seed and Series A stages to help bridge the gap between scientific discovery and commercialization.

Industry: Investors

Beyond the preview

Go deeper on Babel Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Babel Ventures.

Explore the full profile